🔴 Illumina is trading 4.1% down today as hotter September inflation revives rate concerns

Illumina is trading 4.14% down at $260.50, with hotter-than-expected September inflation and technology-share weakness the likeliest pressures.

• Inflation revived concerns about higher-for-longer rates; the Nasdaq is down 0.75%. The biotech sector is higher, so sector weakness does not explain the decline.
• No clear new company-specific catalyst was found. Illumina’s recent server-security recall and BioInsight launch drew attention, but available reporting does not directly link either to the drop.